Arkolith/Insider Trading/CYCC/Form 4

Lazar David E.

10% OwnerCyclacel Pharmaceuticals, Inc. (CYCC) · full profile →Form 4 · filed Aug 4, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$83K
Net Open-Market Flow
-$83K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 30, 2025Sell(S)7K$12.36$83K156K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000921895-25-002082) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML